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PAYING PARTICIPANTS IN ADDICTION RESEARCH -IS CASH KING?
"I know there's some real scary, hardcore stories of people selling vouchers, but I've never experienced anything like that. If I got a voucher, I would often see it as a bonus. If it was for a shop I didn't use, I would sell it to someone I knew for the same amount of money -them just doing me a favour really. I wouldn't sell a voucher for less than its value."
The National Addiction Centre (NAC) at King's College London (UK) and the Aurora Project in Lambeth (UK) jointly organise an addiction Service User Research Group (SURG) 1 . The SURG operates as a Patient and Public Involvement (PPI) panel for addiction researchers; that is, its central aim is to build meaningful and reciprocal relationships between addiction researchers and addiction service users when thinking through research problems, designing studies, preparing grant applications and ultimately conducting studies.
Researchers from the NAC book initial advice sessions with the SURG to talk about their research and to establish relationships with group members who can then go on to be coapplicants or collaborators on studies.
In one recent advice session, SURG members began an impromptu discussion about whether participants in addiction research studies should be 'paid' 2 in cash or by voucher. There is a small and useful literature on paying participants in addiction research (e.g. Fry et al., 2005 Fry et al., , 2006 Ritter et al., 2003; Seddon, 2005) , but these publications largely focus on ethical and to a lesser extent practical concerns from a researcher perspective. In contrast, very little seems to be known about how research participants themselves view payments (for a useful exception see Slomka et al., 2007) . Obviously, the SURG is just one group, in one city, so we do not propose to offer any definitive statements or conclusions on this topic. However, our discussion (which continued later by email) highlighted a number of issues that seem likely to be of interest to other researchers, ethics committee members, and (of course) study participants.
To begin, SURG members identified various benefits of cash payments. On a practical level, cash was considered simple, easy, and convenient: "you can spend it on what you want, when you want, and where you want". In addition, cash has important symbolic value, signifying "a genuine appreciation of the participant's time and contribution". Further, giving a research participant cash indicates "respect" and "trust" in the participant; so "treating them like an adult". As such, cash was perceived as "empowering", "non-stigmatizing" and "potentially encouraging of recovery"; cash was "king". Despite this, group members also acknowledged that cash could easily be spent on drugs or alcohol and this might be the main factor motivating individuals to participate in a study. Even so, there was agreement that in practice the amounts of money offered by studies were nearly always too small to raise any significant safety or ethical concerns, even when study payments were used to buy substances.
Overall, SURG members reported fewer benefits of vouchers compared with cash. Some suggested that vouchers might be better for people who were still using substances as vouchers may remove the "temptation to spend money unwisely". Moreover, vouchers could "encourage people to spend on things that they need" (e.g. food). If people chose to sell vouchers for cash, then group members generally did not feel that that was the responsibility of researchers. In contrast, vouchers seemed to have many disadvantages. For example, vouchers have to be spent in certain shops and/ or on certain things. They also expire and part of the value is lost if goods purchased do not match the value of the voucher (since most retailers do not give cash change). Equally importantly, vouchers can convey lack of trust and "an assumption" that cash would be spent on drugs or alcohol. Indeed, some group members felt very strongly that vouchers were "degrading", "patronizing" or "insulting": "I'm mindful of all the issues involved, and the policies already in place, but it's a matter of respect… I know that some people might be vulnerable to temptation, but, then, when do we qualify for being acknowledged as independent thinkers, and able enough to make own choices?"
More unexpectedly, at least for the researchers present, vouchers were described as "dangerous". SURG members believed that study participants who desperately needed drugs or alcohol might feel they "have to sell their vouchers" and reselling involved finding a "dodgy street dealer" who would accept vouchers, then further bargaining over the value of the vouchers (in terms of either cash or drugs). This led to additional discussions about the resale value of a study voucher, with general agreement being that locally vouchers were exchangeable for half their cash value (i.e. a £20 voucher = £10 cash). In this regard, vouchers were described as "obstacles". That is, a voucher would not prevent a research payment from being spent on drugs or alcohol; it simply made the process longer, trickier and, in consequence, "riskier".
From here, the discussion turned to the type of voucher being offered. All group members agreed that vouchers should be easy to redeemso multi outlet (high street) vouchers that could be redeemed in a number of stores were preferred over single outlet vouchers. In addition, vouchers for cheaper supermarkets were generally preferred over vouchers for more expensive supermarkets -as more goods could be bought (although with the caveat that the resale value of a more upmarket supermarket voucher was estimated to be greater than the equivalent voucher for a budget store). In terms of the amount of payment, £7.50 or less was regarded as insulting. Meanwhile, some group members felt that payment should be capped at £20 per half day's time, some felt that no sum could be too much, and others felt that the amount should depend on what the participant was being asked to do and for how long. As a couple of group members noted, the London living wage is £9:40 per hour and it might be best to ask the question the other way around: "what would researchers expect to be paid for an hour's work?".
The importance of researchers talking to study participants about what was being paid and why was also emphasised. For example, some group members remembered how they been happy to accept vouchers after researchers had explained to them at the very outset that it was hospital or university policy only to offer vouchers (even though they felt that such policies should be challenged as they were discriminatory). Some group members stated that they were also willing to accept vouchers when involved in studies where some participants were vulnerable and might use cash payments "unwisely". Interestingly, group members were also very mindful of the effects that offering payment by cash or voucher might have on study recruitment and sample bias. Specifically, cash was considered to be better at attracting a wider range of participants, including those with ongoing substance use issues. In contrast, vouchers were perceived as biasing recruitment towards participants who are more "stable" in treatment: "I just know that I would have done cash studies when I was active [drinking] and wouldn't have done voucher studies". So is cash always king? Some group members thought so, but some were less sure: "an easily redeemed voucher would also be good in my mind". Others agreed that it very much depended on someone's stage in recovery, with people who were "later on in recovery" becoming more "tolerant" and "accepting" of vouchers. As one group member explained: As we see, even amongst one small group of service users we find very different views, as well as recognition that views change over time and depending on myriad factors, such as the amount of the payment, the ease of redeeming a voucher, what the research involved, the explanation of the payment method offered by the researchers, personal stage of recovery, and a participant's personal finances. If we want an academic term to capture this, we might argue that payment for participation in research constitutes an 'assemblage' (Deleuze and Guattari, 1980) . By this we mean, it is not fixed or stable, but relates to complex constellations of material and non-material factors and the relationships between those factors. We cannot understand payments without connecting them to the social contexts in which they are made and received, the actors involved, and the power dynamics and politics at play.
It is clear that our group has no concrete answers; we have simply scratched the surface of a complex issue needing further study. However, the discussion has at least two implications.
First, researchers and ethics committee members should not be prescriptive about how to pay participants in addiction research; there is no simple simple answer. Second, in planning their studies, researchers need to consult with members of their target participant population to ensure that the decisions they make about payment are well informed. (c.f. Fry et al., 2006) . Payment for participation in research is variously 'compensation', 'incentive', 'reimbursement', 'reward', 'insult', 'danger', 'obstacle', 'recruitment method', and 'king'. Researchers should remember this. Meanwhile, the reflections reported here have potential relevance beyond the world of research. Those working in the addiction field are increasingly delivering interventions (e.g. personal budgets and contingency management) that also involve offering people who use drugs or alcohol money, vouchers or material goods that have an exchangeable cash value. The meanings attributed to such 'payments' similarly need to be considered very carefully from the recipients' perspectives, particularly if we want to avoid negative unintended consequences.
